Atropa belladonna

Tachycardia (typically 100–150 bpm) is a primary pharmacological effect of belladonna alkaloid exposure via cardiac M2 receptor blockade. In individuals with pre-existing cardiac arrhythmias, tachyarrhythmias, or conduction abnormalities, this added cardiac stress can precipitate life-threatening cardiac events. Case reports document tachycardia as a consistent feature of belladonna poisoning.

Myasthenia gravis involves autoimmune destruction of nicotinic acetylcholine receptors at the neuromuscular junction. While belladonna alkaloids primarily target muscarinic receptors, the overall anticholinergic burden and potential interference with cholinesterase inhibitor therapy (standard MG treatment) make exposure contraindicated. This is a class-level contraindication inherited from the anticholinergic drug class.

Belladonna-induced anticholinergic delirium can be clinically indistinguishable from acute psychosis. In individuals with pre-existing psychiatric conditions, the experience may be particularly prolonged, distressing, or destabilizing. Differential diagnosis includes neuroleptic malignant syndrome and serotonin syndrome, complicating clinical management in patients with psychiatric medication histories.

Belladonna alkaloids block M3 muscarinic receptors in the bladder detrusor muscle, impairing contraction and causing urinary retention. In individuals with pre-existing prostatic hypertrophy or urinary outflow obstruction, this can precipitate acute urinary retention requiring catheterization. Urinary retention is a documented feature of anticholinergic toxidrome.

Atropine and scopolamine are confirmed to cross the placental barrier. While teratogenicity has not been established in published studies, fetal exposure to anticholinergic alkaloids occurs with maternal ingestion. Use during pregnancy requires clinical monitoring. No controlled studies on belladonna use in pregnancy exist.

Children are the highest-risk group for belladonna toxicity. Fatal pediatric doses below 10 mg atropine equivalent are documented. The sweet taste and visual resemblance of belladonna berries to edible fruits (bilberries, blueberries) present significant accidental ingestion risk. Over 400 adverse events including seizures in infants were reported in connection with homeopathic belladonna teething tablets between 2006 and 2016.

Elderly individuals demonstrate greater sensitivity to anticholinergic cognitive effects. Cumulative anticholinergic burden from medications is associated with increased risk of cognitive impairment and dementia. Belladonna exposure adds significant anticholinergic load, potentially precipitating or worsening cognitive dysfunction in this population.

Belladonna alkaloids block M3 muscarinic receptors in the iris sphincter and ciliary muscle, causing mydriasis and cycloplegia. In anatomically predisposed eyes (narrow anterior chamber angle), this can precipitate acute angle-closure glaucoma — a medical emergency involving rapid intraocular pressure elevation, severe eye pain, and potential permanent vision loss.

Co-administration of belladonna with any anticholinergic medication — including tricyclic antidepressants, first-generation antihistamines, phenothiazine antipsychotics, antiparkinsonian agents, and bladder antispasmodics — produces additive muscarinic receptor blockade. This increases the risk of precipitating severe anticholinergic toxidrome, including delirium, hyperthermia, and cardiac complications.

Paralytic ileus, Bowel obstruction

Anticholinergic agents decrease gastrointestinal motility via M3 receptor blockade. In patients with paralytic ileus or mechanical bowel obstruction, belladonna alkaloids can worsen the obstruction. This is a class-level contraindication inherited from the anticholinergic drug class.

Anticholinergic agents reduce gastric motility and delay gastric emptying. In patients with pyloric stenosis, this can exacerbate obstruction. This is a class-level contraindication inherited from the anticholinergic drug class and is not specifically discussed in belladonna case reports.